Article Details
Retrieved on: 2024-06-21 20:49:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Rodman & Renshaw assumed coverage on Alto Neuroscience in a research report on Friday. They issued a "buy" rating and a $43.00 target price for ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here